Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections

Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,745 · see citing works

Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

Brooke, J. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-11 · Cited by 1,434 · see citing works

Molecular Properties of Bacterial Multidrug Transporters

Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 792 · see citing works

Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

Jones, R. N. (2010) · Clinical Infectious Diseases · doi:10.1086/653053 · Cited by 716 · see citing works

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

Looney, W. J., Narita, M., & Mühlemann, K. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70083-0 · Cited by 553 · see citing works

The complete genome, comparative and functional analysis of Stenotrophomonas maltophiliareveals an organism heavily shielded by drug resistance determinants

Crossman, L. C., Gould, V. C., Dow, J. M., et al. (2008) · Genome biology · doi:10.1186/gb-2008-9-4-r74 · Cited by 546 · see citing works

Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K. C., & The Sentry Participants Group (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1762 · Cited by 539 · see citing works

Emerging Importance of Multidrug‐Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

Gales, A. C., Jones, R. N., Forward, K. R., Liñares, J., Sader, H. S., & Verhoef, J. (2001) · Clinical Infectious Diseases · doi:10.1086/320183 · Cited by 441 · see citing works

Contemporary Assessment of Antimicrobial Susceptibility Testing Methods for Polymyxin B and Colistin: Review of Available Interpretative Criteria and Quality Control Guidelines

Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 381 · see citing works

Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

Pfaller, M. A., Jones, R. N., & Beach, M. L. (1999) · Clinical Infectious Diseases · doi:10.1086/598640 · Cited by 312 · see citing works

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)

Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302 · see citing works

β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein

Moyá, B., Dötsch, A., Juan, C., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000353 · Cited by 288 · see citing works

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

Morrissey, I., Hackel, M., Badal, R. E., Bouchillon, S. K., Hawser, S., & Biedenbach, D. J. (2013) · Pharmaceuticals · doi:10.3390/ph6111335 · Cited by 257 · see citing works

Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis

Valenza, G., Tappe, D., Turnwald, D., Frosch, M., König, C., Hebestreit, H. U., & Abele‐Horn, M. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.06.006 · Cited by 252 · see citing works

Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012

Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.007 · Cited by 249 · see citing works

Antimicrobial therapy for Stenotrophomonas maltophilia infections

Nicodemo, A. C., & Páez, J. I. G. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0279-3 · Cited by 247 · see citing works

Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer

Safdar, A., & Rolston, K. V. I. (2007) · Clinical Infectious Diseases · doi:10.1086/522998 · Cited by 224 · see citing works

Global Emergence of Trimethoprim/Sulfamethoxazole Resistance inStenotrophomonas maltophiliaMediated by Acquisition ofsulGenes

Toleman, M. A., Bennett, P. M., Bennett, D. M., et al. (2007) · Emerging infectious diseases · doi:10.3201/eid1304.061378 · Cited by 218 · see citing works

Cloning and Characterization of SmeDEF, a Novel Multidrug Efflux Pump from Stenotrophomonas maltophilia

Alonso, A., & Martínez, J. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3079-3086.2000 · Cited by 207 · see citing works

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Lu, P., Liu, Y.-C., Toh, H. S., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(12)70008-0 · Cited by 203 · see citing works

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

Vartivarian, S. E., Anaissie, E., Bodey, G. P., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.624 · Cited by 200 · see citing works

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)

Streit, J. M., Jones, R. N., Sader, H. S., et al. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 192 · see citing works

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

Sader, H. S., & Jones, R. N. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.002 · Cited by 188 · see citing works

Tigecycline: an update

Stein, G. E., & Babinchak, T. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.004 · Cited by 183 · see citing works

Regulatory components in Citrobacter freundii ampC beta-lactamase induction.

Lindberg, F. P., Westman, L., & Normark, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4620 · Cited by 182 · see citing works

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

Falagas, M. E., Valkimadi, P.-E., Huang, Y., Matthaiou, D. K., & Hsueh, P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn301 · Cited by 179 · see citing works

Attributable Mortality of Stenotrophomonas Maltophilia Infections: A Systematic Review of the Literature

Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., et al. (2009) · Future Microbiology · doi:10.2217/fmb.09.84 · Cited by 179 · see citing works

Bacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic Malignancies

Micozzi, A., Venditti, M., Monaco, M., Friedrich, A. W., Taglietti, F., Santilli, S., & Martino, P. (2000) · Clinical Infectious Diseases · doi:10.1086/314043 · Cited by 176 · see citing works

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2008)

Zhanel, G. G., DeCorby, M. R., Adam, H. J., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00469-10 · Cited by 167 · see citing works

SENTRY antimicrobial surveillance program report: latin american and brazilian results for 1997 through 2001

Sader, H. S., Jones, R. N., Gales, A. C., et al. (2004) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702004000100004 · Cited by 159 · see citing works

Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces

de Oliveira-Garcia, D., DallʼAgnol, M., Rosales, M., et al. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00306.x · Cited by 158 · see citing works

Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997

Jones, R. N., Kugler, K. C., Pfaller, M. A., et al. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00158-8 · Cited by 155 · see citing works

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

Zhanel, G. G., Adam, H. J., Baxter, M. R., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt022 · Cited by 149 · see citing works

New strategies againstStenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen

Brooke, J. S. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.864553 · Cited by 148 · see citing works

SmeC, an Outer Membrane Multidrug Efflux Protein of Stenotrophomonas maltophilia

Li, X.-Z., Zhang, L., & Poole, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.333-343.2002 · Cited by 147 · see citing works

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)

Farrell, D. J., Sader, H. S., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.032 · Cited by 146 · see citing works

Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron

Hu, L., Chang, X. L., Ye, Y., et al. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.025 · Cited by 146 · see citing works

Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review

Páez, J. I. G., & Costa, S. F. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.05.020 · Cited by 144 · see citing works

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Doern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K. C., & Beach, M. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00162-x · Cited by 140 · see citing works

Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000)

Hoban, D. J., Biedenbach, D. J., Mutnick, A. H., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00540-0 · Cited by 136 · see citing works

Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome

Samonis, G., Karageorgopoulos, D. E., Maraki, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037375 · Cited by 136 · see citing works

Community-acquired Stenotrophomonas maltophilia infections: a systematic review

Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0709-5 · Cited by 134 · see citing works

Frequency of Isolation of Pathogens from Bloodstream, Nosocomial Pneumonia, Skin and Soft Tissue, and Urinary Tract Infections Occurring in European Patients

Fluit, A. C., Schmitz, F., & Verhoef, J. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100455 · Cited by 132 · see citing works

Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.

Lai, C.-H., Chi, C.-Y., Chen, H., et al. (2004) · PubMed · Cited by 129 · see citing works

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001)

Jones, R. N., Sader, H. S., & Beach, M. L. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00245-0 · Cited by 129 · see citing works

Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections

Wang, Y. L., Scipione, M. R., Dubrovskaya, Y., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-13 · Cited by 127 · see citing works

Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC β-lactamase

Lodge, J., Minchin, S., Piddock, L. J. V., et al. (1990) · Biochemical Journal · doi:10.1042/bj2720627 · Cited by 126 · see citing works

Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients

Pompilio, A., Crocetta, V., Confalone, P., et al. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-102 · Cited by 123 · see citing works

Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli

Hombach, M., Bloemberg, G. V., & Böttger, E. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr524 · Cited by 123 · see citing works

Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies

Entenza, J. M., & Moreillon, P. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.006 · Cited by 122 · see citing works

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

Sader, H. S., Jones, R. N., Gales, A. C., et al. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00124-2 · Cited by 122 · see citing works

Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants

Sánchez, M. B., Hernández, A., Rodríguez-Martínez, J. M., et al. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-148 · Cited by 116 · see citing works

In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012

Walkty, A. J., Adam, H. J., Baxter, M. R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02744-13 · Cited by 115 · see citing works

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit

Sader, H. S., Jones, R. N., Dowzicky, M. J., & Fritsche, T. R. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.002 · Cited by 114 · see citing works

Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

Sader, H. S., Jones, R. N., Stilwell, M. G., et al. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.05.005 · Cited by 114 · see citing works

Frequency of Isolation and Antimicrobial Resistance of Gram-Negative and Gram-Positive Bacteria from Patients in Intensive Care Units of 25 European University Hospitals Participating in the European Arm of the SENTRY Antimicrobial Surveillance Program 1997–1998

Fluit, A. C., Verhoef, J., Schmitz, F., & Participants, T. E. S. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960100564 · Cited by 113 · see citing works

Induction of L1 and L2 β-Lactamase Production inStenotrophomonas maltophiliaIs Dependent on an AmpR-Type Regulator

Okazaki, A., & Avison, M. B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-07 · Cited by 112 · see citing works

Antimicrobial Susceptibilities of a Worldwide Collection of Stenotrophomonas maltophilia Isolates Tested against Tigecycline and Agents Commonly Used for S. maltophilia Infections

Farrell, D. J., Sader, H. S., & Jones, R. N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01774-09 · Cited by 111 · see citing works

Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa , Burkholderia cepacia , Stenotrophomonas maltophilia , and Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis

Saiman, L. M., Chen, Y., Gabriel, P. S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1105-1107.2002 · Cited by 110 · see citing works

Stenotrophomonas maltophilia drug resistance

Sánchez, M. B., Hernandez, A., & Martínez, J. L. (2009) · Future Microbiology · doi:10.2217/fmb.09.45 · Cited by 109 · see citing works

Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents

Fedler, K. A., Biedenbach, D. J., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.003 · Cited by 106 · see citing works

Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009−2011

Bouchillon, S. K., Badal, R. E., Hoban, D. J., et al. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.03.022 · Cited by 105 · see citing works

Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study

Magret, M., Lisboa, T., Martin-Loeches, I., Máñez, R., Nauwynck, M., Wrigge, H., Cardellino, S., Díaz, E., Koulenti, D., Rello, J., et al. (2011) · Critical Care · doi:10.1186/cc10036 · Cited by 105 · see citing works

Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?

Cho, S. Y., Kang, C., Kim, J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-13 · Cited by 104 · see citing works

The SmeYZ Efflux Pump of Stenotrophomonas maltophilia Contributes to Drug Resistance, Virulence-Related Characteristics, and Virulence in Mice

Lin, Y.-T., Huang, Y.-W., Chen, S.-J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00372-15 · Cited by 104 · see citing works

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

MacLeod, D. L., Barker, L. M., Sutherland, J. L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp282 · Cited by 101 · see citing works

Antimicrobial Susceptibility and Synergy Studies of Stenotrophomonas maltophilia Isolates from Patients with Cystic Fibrosis

Gabriel, P. S., Zhou, J. J., Tabibi, S., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.168-171.2004 · Cited by 100 · see citing works

In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods

Nicodemo, A. C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh128 · Cited by 99 · see citing works

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections

O’Riordan, W. D., Mehra, P., Manos, P., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.10.009 · Cited by 98 · see citing works

Class 1 Integrons Increase Trimethoprim-Sulfamethoxazole MICs against Epidemiologically Unrelated Stenotrophomonas maltophilia Isolates

Barbolla, R. E., Catalano, M., Orman, B. E., Famiglietti, A. M. R., Vay, C. A., Smayevsky, J., Centrón, D., & Piñeiro, S. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.666-669.2004 · Cited by 98 · see citing works

Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections

Falagas, M. E., Vardakas, K. Z., Tsiveriotis, K., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.006 · Cited by 97 · see citing works

Clinical Epidemiology of Stenotrophomonas maltophilia Colonization and Infection

TORO, M. D. D., Rodríguez‐Baño, J., Herrero, M., et al. (2002) · Medicine · doi:10.1097/00005792-200205000-00006 · Cited by 96 · see citing works

Xanthomonas maltophilia Bacteremia in Immunocompromised Hematological Patients

Victor, M., Arpi, M., Bruun, B., et al. (1994) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549409011780 · Cited by 93 · see citing works

Xanthomonas maltophilia bacteremia: an analysis of 32 cases.

Jang, T. N., Wang, F. D., Wang, L. S., et al. (1992) · PubMed · Cited by 92 · see citing works

Contribution of Resistance-Nodulation-Division Efflux Pump Operon smeU1-V-W-U2-X to Multidrug Resistance of Stenotrophomonas maltophilia

Chen, C.-H., Huang, C., Chung, T.-C., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00317-11 · Cited by 90 · see citing works

Aph(3′)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia

Okazaki, A., & Avison, M. B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00795-06 · Cited by 90 · see citing works

A Function of SmeDEF, the Major Quinolone Resistance Determinant of Stenotrophomonas maltophilia, Is the Colonization of Plant Roots

García‐León, G., Hernández, A., Hernando‐Amado, S., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.01058-14 · Cited by 88 · see citing works

Outbreak of Stenotrophomonas maltophilia Bacteremia in Allogenic Bone Marrow Transplant Patients: Role of Severe Neutropenia and Mucositis

Labarca, J. A., Leber, A. L., Kern, V., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313591 · Cited by 88 · see citing works

Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options

Castanheira, M., Mendes, R. E., & Jones, R. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu706 · Cited by 85 · see citing works

MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation

Lin, Y.-T., Huang, Y.-W., Liou, R.-S., Chang, Y.-C., & Yang, T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku317 · Cited by 85 · see citing works

Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia

Li, X.-Z. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg148 · Cited by 84 · see citing works

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I—results from the SENTRY Antimicrobial Surveillance Program (North America, 1998)

Mathai, D., Lewis, M. T., Kugler, K. C., et al. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00234-0 · Cited by 83 · see citing works

AmpDIIs Involved in Expression of the Chromosomal L1 and L2 β-Lactamases ofStenotrophomonas maltophilia

Yang, T., Huang, Y.-W., Hu, R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01513-08 · Cited by 83 · see citing works

SmQnr Contributes to Intrinsic Resistance to Quinolones in Stenotrophomonas maltophilia

Sánchez, M. B., & Martínez, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00496-09 · Cited by 83 · see citing works

Antimicrobial Susceptibilities of Unique Stenotrophomonas maltophilia Clinical Strains

Valdezate, S., Vindel, A., Loza, E., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1581-1584.2001 · Cited by 81 · see citing works

Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients

Fujita, J., Yamadori, I., Xu, G., et al. (1996) · Respiratory Medicine · doi:10.1016/s0954-6111(96)90242-5 · Cited by 81 · see citing works

Antimicrobial resistance among non-fermenting Gram-negative bacteria in Saudi Arabia

Memish, Z. A., Shibl, A. M., Kambal, A. M., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks091 · Cited by 78 · see citing works

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000)

Gales, A. C., Sader, H., & Jones, R. N. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00499-6 · Cited by 77 · see citing works

Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study

Zhanel, G. G., Adam, H. J., Low, D. E., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.025 · Cited by 75 · see citing works

An Inducible Fusaric Acid Tripartite Efflux Pump Contributes to the Fusaric Acid Resistance in Stenotrophomonas maltophilia

Hu, R., Liao, S.-T., Huang, C., Huang, Y.-W., & Yang, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051053 · Cited by 72 · see citing works

Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination

Felegie, T. P., Yu, V. L., Rumans, L. W., et al. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.6.833 · Cited by 71 · see citing works

Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011)

Sader, H. S., Flamm, R. K., & Jones, R. N. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.009 · Cited by 70 · see citing works

Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated

Vartivarian, S. E. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.4.433 · Cited by 70 · see citing works

Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation

Al‐Anazi, K. A., & Al-Jasser, A. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00232 · Cited by 69 · see citing works

Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients

Lai, C.-H., Wong, W. W., Chin, C., et al. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01511.x · Cited by 68 · see citing works

The Efflux Pump SmeDEF Contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia

Sánchez, M. B., & Martínez, J. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-15 · Cited by 68 · see citing works

Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species

Hotta, G., Matsumura, Y., Kato, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112208 · Cited by 67 · see citing works

Interplay between intrinsic and acquired resistance to quinolones in S tenotrophomonas maltophilia

García‐León, G., Salgado, F., Oliveros, J. C., et al. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12408 · Cited by 66 · see citing works

In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis

King, P. A., Lomovskaya, O., Griffith, D. C., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00248-09 · Cited by 66 · see citing works

Sm qnr , a New Chromosome-Carried Quinolone Resistance Gene in Stenotrophomonas maltophilia

Shimizu, K., Kikuchi, K., Sasaki, T., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00026-08 · Cited by 65 · see citing works

Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia

Moskowitz, S. M., Garber, E., Chen, Y., Clock, S. A., Tabibi, S., Miller, A. K., Doctor, M., & Saiman, L. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq131 · Cited by 65 · see citing works

Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units)

Meyer, E., Schwab, F., Gastmeier, P., et al. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.07.006 · Cited by 64 · see citing works

Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06

Livermore, D. M., Hope, R., Brick, G., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn352 · Cited by 63 · see citing works

In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia

Poulos, C., Matsumura, S., Willey, B., et al. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2220 · Cited by 63 · see citing works

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006

Zhanel, G. G., DeCorby, M. R., Nichol, K. A., et al. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.04.012 · Cited by 62 · see citing works

Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Stenotrophomonas maltophilia from Cystic Fibrosis Patients

Milne, K., & Gould, I. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00072-12 · Cited by 62 · see citing works

Stenotrophomonas (Xanthomonas) maltophilia Urinary Tract Infection

Vartivarian, S. E. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040111012 · Cited by 62 · see citing works

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Jones, R. N., Croco, M. A. T., Kugler, K. C., Pfaller, M. A., & Beach, M. L. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00115-2 · Cited by 61 · see citing works

A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan

Wu, H., Wang, J.-T., Shiau, Y., et al. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.09.028 · Cited by 61 · see citing works

Coordinate Hyperproduction of SmeZ and SmeJK Efflux Pumps Extends Drug Resistance in Stenotrophomonas maltophilia

Gould, V. C., Okazaki, A., & Avison, M. B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-12 · Cited by 60 · see citing works

In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

Hornsey, M., Longshaw, C. M., Phee, L. M., & Wareham, D. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05870-11 · Cited by 60 · see citing works

Stenotrophomonas maltophilia bloodstream infection: Comparison between community-onset and hospital-acquired infections

Chang, Y.-T., Lin, C., Lu, P., et al. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.014 · Cited by 59 · see citing works

The sul1 Gene in Stenotrophomonas maltophilia With High-Level Resistance to Trimethoprim/Sulfamethoxazole

Chung, H., Kim, K., Hong, S. S., et al. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.2.246 · Cited by 58 · see citing works

Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia

Giamarellos‐Bourboulis, E. J., Karnesis, L., & Giamarellou, H. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00443-1 · Cited by 58 · see citing works

Molecular cloning and characterization of SmrA, a novel ABC multidrug efflux pump from Stenotrophomonas maltophilia

Al-Hamad, A., Upton, M., & Burnie, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp271 · Cited by 57 · see citing works

Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia

Huang, Y.-W., Hu, R., Chu, F., Lin, H.-R., & Yang, T. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt250 · Cited by 57 · see citing works

A Linkage between SmeIJK Efflux Pump, Cell Envelope Integrity, and σE-Mediated Envelope Stress Response in Stenotrophomonas maltophilia

Huang, Y.-W., Liou, R.-S., Lin, Y.-T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111784 · Cited by 56 · see citing works

Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital

Gülmez, D., & Hasçelik, G. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01257.x · Cited by 54 · see citing works

High-level quinolone resistance is associated with the overexpression of smeVWX in Stenotrophomonas maltophilia clinical isolates

García‐León, G., Puig, C. R. D. A., de la Fuente, C. G., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.01.007 · Cited by 53 · see citing works

Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing

Gülmez, D., Çakar, A., Şener, B., et al. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0068-2 · Cited by 53 · see citing works

Antimicrobial Susceptibility ofStenotrophomonas maltophiliaIsolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates

Chung, H., Chong, Y., Kim, Y. R., et al. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.1.62 · Cited by 53 · see citing works

Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity

Flores-Treviño, S., Gutiérrez-Ferman, J. L., Morfín‐Otero, R., Rodríguez-Noriega, E., Estrada‐Rivadeneyra, D., Rivas-Morales, C., Llaca-Díaz, J. M., Camacho-Ortíz, A., Mendoza-Olazarán, S., & Garza‐González, E. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.074385-0 · Cited by 52 · see citing works

Biofilm Compared to Conventional Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

Wu, K., Yau, Y. C. W., Matukas, L. M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02215-12 · Cited by 52 · see citing works

SmeOP-TolC Sm Efflux Pump Contributes to the Multidrug Resistance of Stenotrophomonas maltophilia

Lin, C., Huang, Y.-W., Hu, R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01974-13 · Cited by 51 · see citing works

Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai

Tan, R., Liu, J., Li, M., et al. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.11.006 · Cited by 49 · see citing works

Stenotrophomonas maltophilia – The most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: A prospective multicenter study

Fihman, V., Monnier, A. L., Corvec, S., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.01.001 · Cited by 49 · see citing works

New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas

Waters, V. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315939 · Cited by 49 · see citing works

In Vitro and In Vivo Properties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases

Page, M. G. P., Dantier, C., Desarbre, E., Gaucher, B., Gebhardt, K., & Schmitt‐Hoffmann, A. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01370-10 · Cited by 49 · see citing works

Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates

Cantón, R., Valdezate, S., Vindel, A., et al. (2003) · Pediatric Pulmonology · doi:10.1002/ppul.10216 · Cited by 48 · see citing works

Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012)

Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02684-13 · Cited by 47 · see citing works

Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002–2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)

Yang, Q., Wang, H., Chen, M., Ni, Y., Yu, Y., Hu, B., Sun, Z., Huang, W., Hu, Y., Ye, H., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.09.001 · Cited by 46 · see citing works

Structural and Functional Analysis of SmeT, the Repressor of the Stenotrophomonas maltophilia Multidrug Efflux Pump SmeDEF

Hernández, A., Maté, M. J., Sánchez-Díaz, P. C., Romero, A., Rojo, F., & Martínez, J. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809221200 · Cited by 46 · see citing works

Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia

CHOW, A. W. C., Wong, J., & Bartlett, K. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.782 · Cited by 46 · see citing works

Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-Enteric Gram-negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes

Jones, R. N., Pfaller, M. A., Marshall, S. A., et al. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)81808-1 · Cited by 44 · see citing works

In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)

Liu, Y.-M., Chen, Y.-S., Toh, H. S., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(12)70004-3 · Cited by 44 · see citing works

Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains

Valdezate, S., Vindel, A., Sáez-Nieto, J. A., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki182 · Cited by 44 · see citing works

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010

Chen, Y., Lu, P., Huang, C.-H., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06053-11 · Cited by 43 · see citing works

Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections

Tekce, Y. T., Erbay, A., Çabadak, H., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1120009x12z.00000000022 · Cited by 42 · see citing works

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia

Betts, J. W., Phee, L. M., Woodford, N., & Wareham, D. W. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2101-3 · Cited by 42 · see citing works

In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives

Rizek, C., Ferraz, J. R., van der Heijden, I. M., et al. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.10.009 · Cited by 40 · see citing works

Activities of Three Quinolones, Alone and in Combination with Extended-Spectrum Cephalosporins or Gentamicin, against Stenotrophomonas maltophilia

Visalli, M. A., Jacobs, M. R., & Appelbaum, P. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2002 · Cited by 40 · see citing works

Synergistic Interaction in Vitro with Use of Three Antibiotics Simultaneously against Pseudomonas maltophilia

Yu, V. L., Felegie, T. P., Vee, R. B., et al. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/142.4.602 · Cited by 39 · see citing works

Synergistic Effect of Combinations of Sulfamethoxazole, Trimethoprim, and Colistin Against Pseudomonas maltophilia and Pseudomonas cepacia

Nord, C., Wadström, T., & Wretlind, B. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.4.521 · Cited by 38 · see citing works

Treatment of Recurrent Stenotrophomonas maltophilia Ventilator-Associated Pneumonia with Doxycycline and Aerosolized Colistin

Wood, G. C., Underwood, E. L., Croce, M. A., et al. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p217 · Cited by 38 · see citing works

Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study

Wang, C.-H., Lin, J., Lin, H., et al. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.06.005 · Cited by 37 · see citing works

Stenotrophomonas MaltophiliaInfections

Dignani, M. C., Grazziutti, M., & Anaissie, E. J. (2003) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2003-37920 · Cited by 36 · see citing works

Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria

Rattanaumpawan, P., Ussavasodhi, P., Kiratisin, P., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-167 · Cited by 36 · see citing works

Stenotrophomonas maltophilia: An Unusual Cause of Biliary Sepsis

Papadakis, K. A., Vartivarian, S. E., Vassilaki, M. E., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.4.1032 · Cited by 35 · see citing works

Synergy with double and triple antibiotic combinations compared

Berenbaum, M. C., Yu, V. L., & Felegie, T. P. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.6.555 · Cited by 35 · see citing works

AmpN-AmpG Operon Is Essential for Expression of L1 and L2 β-Lactamases inStenotrophomonas maltophilia

Huang, Y.-W., Lin, C., Hu, R., Lin, Y.-T., Chung, T., & Yang, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01283-09 · Cited by 35 · see citing works

Delafloxacin for the treatment of respiratory and skin infections

Bassetti, M., Siega, P. D., Pecori, D., Scarparo, C., & Righi, E. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1005205 · Cited by 35 · see citing works

Antimicrobial susceptibility and combination testing of invasiveStenotrophomonas maltophiliaisolates

Church, D. L., Lloyd, T., Peirano, G., et al. (2012) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2012.732240 · Cited by 33 · see citing works

Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers

Gales, A. C., Sader, H. S., & Fritsche, T. R. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.10.017 · Cited by 33 · see citing works

Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea

Kim, T., Chong, Y. P., Park, S. Y., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.08.011 · Cited by 32 · see citing works

Identification of a Novel 6′- N -Aminoglycoside Acetyltransferase, AAC(6′)-Iak, from a Multidrug-Resistant Clinical Isolate of Stenotrophomonas maltophilia

Tada, T., Miyoshi‐Akiyama, T., Dahal, R. K., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03354-14 · Cited by 32 · see citing works

Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010

Lee, Y.-L., Chen, Y.-S., Toh, H. S., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(12)70007-9 · Cited by 31 · see citing works

Inactivation of mrcA gene derepresses the basal-level expression of L1 and L2 -lactamases in Stenotrophomonas maltophilia

Lin, C., Lin, H., Huang, Y.-W., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr276 · Cited by 31 · see citing works

The in vitro evaluation of tigecycline tested against pathogens isolated in eight countries in the Asia-Western Pacific region (2008)

Farrell, D. J., Turnidge, J. D., Bell, J. M., Sader, H. S., & Jones, R. N. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.03.024 · Cited by 31 · see citing works

Role of the pcm-tolCsm operon in the multidrug resistance of Stenotrophomonas maltophilia

Huang, Y.-W., Hu, R., & Yang, T. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt148 · Cited by 30 · see citing works

Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria

Livermore, D. M., Mushtaq, S., Warner, M., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt455 · Cited by 28 · see citing works

Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007.

Guembe, M., Cercenado, E., Alcalá, L., et al. (2008) · PubMed · Cited by 27 · see citing works

Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype

Irifune, K., ISHIDA, T., SHIMOGUCHI, K., et al. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.11.2856-2857.1994 · Cited by 26 · see citing works

In Vitro Efficacy of High-Dose Tobramycin against Burkholderia cepacia Complex and Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

Ratjen, A., Yau, Y. C. W., Wettlaufer, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04123-14 · Cited by 25 · see citing works

Investigation of the case numbers of catheter-related bloodstream infection overestimated by the central line-associated bloodstream infection surveillance definition

Chen, X.-X., Lo, Y.-C., Su, L., & Chang, C.-L. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.03.006 · Cited by 24 · see citing works

In vitro activity of tigecycline against isolates collected from complicated skin and skin structure infections and intra-abdominal infections in Africa and Middle East countries: TEST 2007–2012

Renteria, M., Biedenbach, D. J., Bouchillon, S. K., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.017 · Cited by 24 · see citing works

Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital

Pien, C.-J., Kuo, H., Chang, S., et al. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.09.005 · Cited by 23 · see citing works

Distinct groups and antimicrobial resistance of clinical Stenotrophomonas maltophilia complex isolates from Korea

Rhee, J.-Y., Choi, J. Y., Choi, M., et al. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.053355-0 · Cited by 23 · see citing works

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)

Jones, R. N., Croco, M. A. T., Pfaller, M. A., et al. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00432.x · Cited by 22 · see citing works

Involvement of Mutation in ampD I, mrcA , and at Least One Additional Gene in β-Lactamase Hyperproduction in Stenotrophomonas maltophilia

Talfan, A., Mounsey, O., Charman, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-13 · Cited by 21 · see citing works

Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients.

Fluit, A. C., Schmitz, F.-J., & Verhoef, J. (2001) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-8078-8 · Cited by 21 · see citing works

Stenotrophomonas maltophilia Infection Among Young Children in a Cardiac Intensive Care Unit: A Single Institution Experience

Arthur, C., Tang, X., Romero, J. R., et al. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-1041-0 · Cited by 20 · see citing works

The potential role of nemonoxacin for treatment of common infections

Huang, C., Lai, C.-C., Chen, Y., & Hsueh, P. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.978288 · Cited by 20 · see citing works

Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998–2003)

Fedler, K. A., Jones, R. N., Sader, H. S., et al. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.01.005 · Cited by 17 · see citing works

Susceptibility ofStenotrophomonas maltophiliaclinical strains in China to antimicrobial combinations

Hu, L., Gao, L., Ye, Y., et al. (2014) · Journal of Chemotherapy · doi:10.1179/1973947814y.0000000168 · Cited by 17 · see citing works

In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.

Khan, I. U., Mirza, I. A., Ikram, A., et al. (2014) · PubMed · Cited by 17 · see citing works

Meningitis due to Stenotrophomonas maltophilia after a Neurosurgical Procedure

Sood, S. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5614.3248 · Cited by 16 · see citing works

S tenotrophomonas maltophilia: Rare cause of meningitis

Correia, C., Ferreira, S. T., & Nunes, P. (2014) · Pediatrics International · doi:10.1111/ped.12352 · Cited by 15 · see citing works

The Clinical Spectrum of Stenotrophomonas (Xanthomonas) Maltophilia Respiratory Infection

Vartivarian, S. E., Anaissie, E. J., Kiwan, E. N., et al. (2000) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2000-9859 · Cited by 15 · see citing works

Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin

Personne, Y., Curtis, M. A., Wareham, D. W., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku309 · Cited by 15 · see citing works

Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit

Ning, B., Zhang, C., Liu, T., et al. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.757 · Cited by 14 · see citing works

In vitro activity of colistin against Stenotrophomonas maltophilia

Rodríguez, C. H., Nastro, M., Calvo, J. L., et al. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.04.004 · Cited by 14 · see citing works

Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia

Lai, C.-C., Lee, K., Lin, S., Chen, Y., Kuo, H., Hung, C., & Hsueh, P. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.894881 · Cited by 14 · see citing works

Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007

Jean, S., Lee, W., Bai, K., et al. (2013) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2013.07.002 · Cited by 13 · see citing works

Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004–2012

Lee, M., Wang, H., Yang, C., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2060-8 · Cited by 12 · see citing works

A patient presenting with cholangitis due to Stenotrophomonas maltophilia and Pseudomonas aeruginosa successfully treated with intrabiliary colistine

Pérez, P. N., Ramirez, M. A., Fernández, J. A., et al. (2014) · Infectious Disease Reports · doi:10.4081/idr.2014.5147 · Cited by 12 · see citing works

Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem

Kerr, K., Hawkey, P. M., Child, J. A., et al. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.782.1090 · Cited by 10 · see citing works

High-dosage tigecycline for Stenotrophomonas maltophilia bacteremia

Wu, Y., & Zonghong, S. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140364 · Cited by 7 · see citing works

Stenotrophomonas Infection in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency

Harthan, A. A., & Heger, M. L. (2013) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-18.2.137 · Cited by 6 · see citing works

Non-cephalosporin-susceptible, glucose non-fermentative Gram-negative bacilli meningitis in post-neurosurgical adults: Clinical characteristics and therapeutic outcome

Lai, W.-A., Chen, S.-F., Tsai, N., et al. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.10.020 · Cited by 3 · see citing works

Xanthomonas maltophilia

CABI (2019) · CABI Compendium · doi:10.1079/cabicompendium.56951 · Cited by 1 · see citing works

In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.

斎藤, 美., 福澤, め., & Nix, D. E. (2002) · PubMed · doi:10.1016/s0732-8893(01)00281-4

Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections.

Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740 · see citing works

Enhancing artemisinin content in and delivery from Artemisia annua: a review of alternative, classical, and transgenic approaches

Wani, K. I., Choudhary, S., Zehra, A., Naeem, M., Weathers, P., & Aftab, T. (2021) · Planta · doi:10.1007/s00425-021-03676-3 · Cited by 74 · see citing works

Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections

Tekce, Y. T., Erbay, A., Çabadak, H., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1120009x12z.00000000022 · Cited by 42 · see citing works

Molecular investigation of Stenotrophomonas maltophilia isolatesexhibiting rapid emergence of ticarcillin-clavulanate resistance

Barbier-Frebour, N., Boutiba-Boubake, I., Nouvello, M., et al. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0708 · Cited by 20 · see citing works

Antimicrobial Susceptibilities of a Worldwide Collection of Stenotrophomonas maltophilia Isolates Tested against Tigecycline and Agents Commonly Used for S. maltophilia Infections

Farrell, D. J., Sader, H. S., & Jones, R. N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01774-09 · Cited by 111 · see citing works

[Surveillance on antibiotic resistance of Stenotrophomonas maltophilia in Chengdu and Chongqing area].

Tao, C., Li, X., Lu, X., et al. (2004) · PubMed

Lower Respiratory Tract Infection Caused by Stenotrophomonas maltophilia and Associated Antibiotic Susceptibility Analysis

Lihua, Z. (2006) · Zhongguo yiyuan ganranxue zazhi · Cited by 1 · see citing works